Ashish Banerjee Clinical Oncology Society of Australia Annual Scientific Meeting 2024

Ashish Banerjee

Abstracts this author is presenting:

• Post-Progression Survival Outcomes in Patients with Primary Advanced or Recurrent Endometrial Cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial Who Received Follow-up Immunotherapy — Afternoon Tea, Exhibition & Poster Session 1
• Time Course of Adverse Events in Primary Advanced or Recurrent Endometrial Cancer Treated with Dostarlimab Plus Chemotherapy in the ENGOT-EN-6-NSGO/GOG-3031/RUBY Trial — Afternoon Tea, Exhibition & Poster Session 1